Dr. med. Lucas Jörg
Kardiologie · Dept. I
BIOSOLVE IV - Safety and Performance in de Novo Lesions of Native Coronary Arteries with Magmaris
01.11.2018The aim of the BIOSOLVE - IV Swiss Satellite Registry is to investigate the clinical performance and long-term safety of Magmaris in a real world setting and extend clinical practice using the technology in a monitored nationwide registry. Primary En...
Klinische Forschung - 01.11.2018 - 31.03.2022
Abgebrochen
Projektleitung: Jörg Lucas
Mitarbeiter/innen: Schneider Irene
Takotsubo - Clinical Characteristics of Takotsubo Cardiomyopathy
01.04.2018Takotsubo Cardiomyopathy, or broken heart syndrome, is a recently described acquired form of cardiomyopathy whose pathophysiology is not well understood and particularly affects postmenopausal women. The exact mechanism is still unclear and large p...
Klinische Forschung - 01.04.2018 - 31.12.2030
Laufend
Projektleitung: Jörg Lucas
Mitarbeiter/innen: Fink Karin, Schneider Irene
CTO-R: Treatment of coronary chronic total occlusions (CTO) by percutaneous angioplasty (PCI): A single center registry
01.01.2009The aim of the registry is to analyze clinical characteristics, angiographic and clinical follow-up of patients treated for a CTO by PCI. This will help to prove the clinical benefit for these patients. Furthermore we want to prove, that the MACE rat...
Klinische Forschung - 01.01.2009 - 01.01.2013
Automatisch geschlossen
Projektleitung: Weilenmann Daniel
Mitarbeiter/innen: Jörg Lucas, Gemperle Michaela, Schneider Irene